We just finished an incredible meeting with Dr. Robert Timmerman as part of rasident fellows grand round at @MDAndersonNews Two minutes of pure inspiration that will stay with me for a lifetime. He said: “If you think your job is to contour, you can easily be replaced by AI.

This week the 2025 MR-Linac Consortium Meeting is being held in the United Kingdom. Several of our faculty are in attendance and presenting their work. Follow the 🧵for more information on our department talks and presentations during the meeting:

#PancreaticCancer is called the emperor of all maladies. Listen to @NiuSanford on the @NRGonc Podcast on what we’re doing w radiation in GI011 for unresectable pancreas cancer. @lauren_henke @ASCO @ASTRO_org @TedHong9 @UTSW_RadOnc @utswcancer @montypal

Thanks, @lauren_henke & @StephenChunMD, for the opportunity to discuss our pancreas cancer trial on the @NRGonc pod! Listen to learn about NRG-GI011, or just to hear Stephen's sonorous tenor voice 🎶.

Congratulations to Dr. @MonaArbabMD, a physician on our breast disease-oriented team, who was elected as the Director-at-Large of the @ASTRO_org ADROP Executive Committee! As part of this selection, Dr. Arbab will serve a three-year term.

The lead author literally profits from the public fear generated by their JAMA Internal Medicine article. We write about it here....

Want to learn about the newest NRG trial in #pancreaticcancer - Our Podcast co-hosts sit with @NiuSanford to discuss the NRG-GI011 "LAP100" trial of dose escalated RT next week. Follow us where you get your podcasts at https://t.co/2vKAkmhCrN @StephenChunMD @Lauren_Henke

November is #PancreaticCancer awareness month. Listen to @NiuSanford on how we’re using radiation for unresectable pancreas cancer in one of our newest trials @NRGonc GI011. @lauren_henke @TedHong9 @UTSWMedCenter @utswcancer @UTSW_RadOnc @ASCO

We have become very aggressive in bacterial decolonization to help mitigate oral mucositis in head and neck radiotherapy. It is impossible to say whether both interventions at once are better than either one on their own, but anecdotally I have been pleased. They are essentially

RT for massive HCC. In series (n=156) w median tumor size 12.9 cm, local control w RT (+/- opt'l TACE) = 86%. RT dose modest (4Gy x 6-10 fx): HCC is radiosensitive. Recall in RTOG 1112, med size 7.8 cm. IMO among local HCC tx, RT/SBRT has strongest evidence for larger tumors.

Hepatic Arterial Infusion Pump Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma 🔎PUMP-2 Trial @JCO_ASCO https://t.co/EMwfTeeo8Z 👉48 pts HAIP floxuridine + CTx 👉PR: 44%; DCR: 84% 👉1-year OS: 80.0% 🧐strong signal, interesting opportunity for downstaging,

So proud of our amazing therapists!

Congratulations to our radiation therapists for completing certification in online ART contouring! This reflects the teamwork between RTs mastering adaptive skills, physicists building training pipelines for Ethos/Unity, and physicians guiding standards with clinical expertise.

In RAPIDO, higher LRR w short course TNT confined to pts undergoing sphincter-preserving surg (12 v 5%), w distal resection margin <1cm as predictor. Suggests need to re-eval safe margin & consider basing surg off original tumor extent. Caveat: post hoc, exploratory analysis.

‼️ No it’s not about money, which is frankly offensive. It’s about doing the right thing for our patients. It’s about RCT evidence that IORT doesn’t work. From ELIOT trial the probability of greater recurrence in the breast with IORT is 99.999%

Congratulations! So excited to have this novel treatment for our patients!

We are one month away from the 11th Annual Meeting of PTCOG-NA. Book your hotel room at the special room rate at Live! Casino and Hotel Louisiana today! https://t.co/guoha2w2AK

We are six weeks away from the PTOC-NA 11th Annual Meeting in Shreveport, LA! Secure your hotel reservation at the beautiful Live! Casino and Hotel Louisiana before the special rate ends on October 6!

It was such a pleasure to read the results of this juicy and terrific randomized trial of postop RT dose de-escalation for HPV+ OPSCC from @DanielMaMD and colleagues at @MayoRadOnc. The field has been waiting for the formal results, and this paper does not disappoint.

Mitochondria are microscopic. You cannot diagnose “mitochondrial challenges” by glaring at a child in an airport. What you can do is prey on parents fears with pseudoscience, while ignoring the real crises our kids face, like gun violence, food insecurity, and lack of healthcare.